In vivo inhibition of s180 tumors by the synergistic effect of the chinese medicinal herbs coptis chinensis and evodia rutaecarpa

Planta Medica

Volumn 75, Issue 11, 2009, Pages 1215-1220

  Wang, Xiao Na ^a   Xu, Li Na ^a   Peng, Jin Yong ^a,b   Liu, Ke Xin ^a   Zhang, Li Hua ^b   Zhang, Yu Kui ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Coptis chinensis Franch; Evodia rutaecarpa (Juss.) benth; Ranunculaceae; Rutaceae; Synergy; Zuojinwan

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; COPTIS CHINENSIS EXTRACT; CREATINE KINASE; EVODIA RUTAECARPA EXTRACT; LACTATE DEHYDROGENASE; PLANT EXTRACT; PROTEIN BAX; PROTEIN P53; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZUOJINWAN EXTRACT;

ACID PHOSPHATASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CHINESE HERB; CHINESE MEDICINE; CONTROL GROUP; CONTROLLED STUDY; COPTIS; COPTIS CHINENSIS; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EVODIA; EVODIA RUTAECARPA; EXPERIMENTAL MODEL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIFESPAN; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; TUMOR CELL; WILD TYPE; ZUOJINWAN;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COPTIS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; EVODIA; MICE; MICE, INBRED STRAINS; SARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

COPTIS CHINENSIS; EVODIA RUTAECARPA; MUS; RANUNCULACEAE; RUTACEAE;

EID: 70350757629     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185538     Document Type: Article

References (29)

1. Cai Q, Benson MA, Talbot TJ, Devadas G, Swanson HJ, Olson JL, Kirchner JP. Acute hepatitis due to fluoxetine therapy. Mayo Clinic Proceedings 1999; 74: 692-694
2. Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochem Russia 2000; 65: 95-106
3. Kuo MT. Roles of multidrug resistance genes in breast cancer chemoresistance. Adv Exp Med Biol 2007; 608: 23-30
4. Shi LX, Ma R, Lu R, Xu Q, Zhu ZF, Wang L, Zhou CL, Li XL, Zhang HL, Yao Z. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/ 5-FU. Cancer Lett 2008; 269: 101-110
5. Tahiliani P, Kar A. The combined effects of Trigonella and Allium extracts in the regulation of hyperthyroidism in rats. Phytomedicine 2003; 10: 665-668
6. China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China, the first division of 2005 edition. Beijing: China Chemical Industry Press; 2005: 412-413
7. Yang FQ, Zhang TY, Zhang R, Ito Y. Application of analytical and preparative high-speed counter-current chromatography for separation of alkaloids from Coptis chinensis Franch. J Chromatogr A 1998; 829: 137-141
8. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004; 203: 127-137
9. Wu CC, Chan YC, Shuenn JS. Determination of the alkaloids in Evodiae Fructus by high-performance liquid chromatography. J Chromatogr A 1996; 727: 317-323
10. Wang L, Hu CP, Deng PY, Shen SS, Zhu HQ, Ding JS, Tan GS, Li YJ. The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med 2005; 71: 416-419
11. Ko HC,Wang YH, Liou KT, Chen CM, Chen CH,WangWY, Chang S, Hou YC, Chen KT, Chen CF, Shen YC. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 2007; 555: 211-217
12. Yu LL, Liao JF, Chen CF. Anti-diarrheal effect of water extract of Evodiae fructus in mice. J Ethnopharmacol 2000; 73: 39-45
13. Wang XN, Han X, Xu LN, Yin LH, Xu YW, Qi Y, Peng JY. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 2008; 15: 1062-1068
14. Lv X,Wang J, Jiang WQ, Zhang HY. Progress in the research of Coptis chinensis Franch. Shangdong Industry Med 2003; 22: 33-35
15. Zhou YB, Xiong M, Han J, Zhang K. Progress in the research of alkaloids in Evodia rutaecarpa. J Wengshan Teachers College 2008; 21: 102-107
16. Xu SY, Bian RL, Chen X. Experimental methodology of pharmacology. Beijing: People's Medical Publishment House; 2002: 179
17. China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China, the first division of 2005 edition. Beijing: China Chemical Industry Press; 2005: 412
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
19. Pedrycz A, Czerny K. Immunohistochemical study of proteins linked to apoptosis in rat fetal kidney cells following pre-pregnancy adriamycin administration in the mother. Acta Histochem 2008; 110: 519-523
20. Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells. Mol Cell Endocrinol 2007; 264: 74-81
21. Das T, Mallick SK, Paul D, Bhutia SK, Bhattacharyya TK, Maiti TK. Microcontact printing of concanavalin A and its effect on mammalian cell morphology. J Colloid Interface Sci 2007; 314: 71-79
22. Xiong C, Chen X, Guo HL, Yang J. The use of AO/EB double staining for detection of apoptosis. J Yunyang Med College 1997; 2: 68-72
23. Zhang JH,Wan MX, Pan BR, Yu B. Cytotoxicity of HSVtk and hrTNF-α fusion genes with IRES in treatment of gastric cancer. Cancer Lett 2006; 235: 191-201
24. Hayes DF. Tumor marker development: towards validation of clinically useful markers. Eur J Cancer Suppl 2007; 5: 77-81
25. Thangaraju M, Sharma K, Liu D, Shen SH, Srikant CB. Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Res 1999; 59: 1647-1654
26. Usui A, Fujita K, Imaizumi M, Abe T, Inoue K, Matumoto S, Kato K. Determination of creatine kinase isozymes in sera and tissues of patients with various lung carcinomas. Clin Chim Acta 1987; 164: 47-53
27. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006; 9: 425-434
28. Kim E, Giese A, Deppert W. Wild-type p53 in cancer cells: when a guardian turns into a blackguard. Biol Pharmacol 2009; 77: 11-20
29. Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 2003; 169: 1219-1228